Can-Fite BioPharma CANF Ratios (2013-2025)

NYSE CANF

$3.42 +0.02 (+0.59%)

At close: Aug 20, 2026 · 4:00 PM EDT

Ratios	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Profitability
EBT Margin (Quarter)																											-2,159.60%	-1,877.94%	-1,220.38%	-2,898.67%	-1,466.89%	-1,253.20%	-1,354.58%	-3,288.24%	-1,156.10%	-1,014.71%	-1,261.27%	-21,303.85%	-1,383.67%	-1,406.63%	-951.53%	-18,384.52%
EBIT Margin (Quarter)																											-2,159.60%	-1,877.94%	-1,174.88%	-2,368.67%	-1,466.89%	-1,253.20%	-1,398.41%	-1,974.51%	-1,156.10%	-1,014.71%	-1,261.27%	-909.23%	-1,383.67%	-910.20%	-951.53%	-1,183.23%
EBITDA Margin (Quarter)																											-2,159.60%	-1,877.94%	-1,174.88%	-2,368.67%	-1,466.89%	-1,253.20%	-1,398.41%	-1,974.51%	-1,156.10%	-1,014.71%	-1,261.27%	-909.23%	-1,383.67%	-910.20%	-951.53%	-1,183.23%
Operating Margin (Quarter)																											-2,159.60%	-1,877.94%	-1,174.88%	-2,368.67%	-1,466.89%	-1,253.20%	-1,398.41%	-1,974.51%	-1,156.10%	-1,014.71%	-1,261.27%	-909.23%	-1,383.67%	-910.20%	-951.53%	-1,183.23%
Net Margin (Quarter)																											-2,192.93%	6,866.18%	-9,703.79%	-2,898.67%	-1,268.92%	2,790.00%	-5,415.94%	-3,288.24%	-1,187.32%	-1,014.71%	-1,261.27%	-21,303.85%	-1,301.02%	-1,406.63%	-951.53%	-18,384.52%
Efficiency
Assets Average (Quarter)																													13.06M	11.42M	11.13M	11.21M	12.16M	17.45M	19.05M	16.30M	13.73M	10.99M	11.39M	12.26M	10.10M	9.58M	7.96M	7.52M	8.42M	8.62M
Asset Utilization Ratio (Quarter)																													0.06	0.07	0.06	0.07	0.07	0.05	0.05	0.05	0.06	0.07	0.06	0.06	0.07	0.08
Leverage & Solvency
Interest Coverage Ratio (Quarter)																														-0.10				-4.11				-0.04		-1.83		-0.07
Times Interest Earned (Quarter)																														-0.10				-4.11				-0.04		-1.83		-0.07
Valuation
Enterprise Value (Quarter)																												-9.14M	-10.22M	-8.34M	-3.11M	-7.54M	-13.31M	-18.90M	-5.69M	-1.75M	-3.74M	-2.99M	-1.28M	-3.47M	-3.39M	-4.30M	-4.73M	-7.88M	-6.46M	-11.55M
Return Ratios
Return on Sales (Quarter)																											-0.22%	-0.19%	-0.12%	-0.29%	-0.15%	-0.13%	-0.14%	-0.33%	-0.12%	-0.10%	-0.13%	-2.13%	-0.14%	-0.14%	-0.10%	-1.84%
Return on Capital Employed (Quarter)																														-139.23%	-132.63%	-128.06%	-123.59%	-87.27%	-80.77%	-84.69%	-101.02%	-96.50%	-100.49%	-82.28%	-95.60%	-108.41%
Return on Assets (Quarter)																													-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.03%	-0.03%	-0.03%	-0.03%	-0.04%	-0.04%	-0.04%	-0.03%

Can-Fite BioPharma (CANF)

NYSE: CANF

$3.42 ▲ +0.02 (+0.59%)

Aug 20, 2026 · 4:00 PM EDT